Aggressive LDL-C Lowering and the Brain: Impact on Risk for

Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)

Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management

Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage

Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study, Cardiovascular Diabetology

LDL cholesterol: How low can you (safely) go? - Harvard Health

Full article: LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals

Cureus, Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy

Can LDL cholesterol be too low? Possible risks of extremely low levels - Olsson - 2017 - Journal of Internal Medicine - Wiley Online Library

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Relative effects of LDL-C on ischemic stroke and coronary disease

Distribution of the baseline and on-treatment LDL-C levels. LDL-C (mg/dL)